Stay updated on FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial
Sign up to get notified when there's something new on the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page.

Latest updates to the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 has been added, and the notices related to government funding and the previous revision (v3.4.1) have been removed.SummaryDifference0.5%

- Check21 days agoChange DetectedA site-wide notice about funding-related information accuracy and the NIH Clinical Center status was added, and the page revision updated to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and updated metadata to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision label v3.4.0; the previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and v3.3.4 were removed.SummaryDifference0.2%

- Check35 days agoChange DetectedKyntra Bio is now listed as sponsor and responsible party for the study, replacing FibroGen.SummaryDifference0.3%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no substantive changes to the study details are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedLocations section updated with new sites: Hong Kong Island, Kowloon, New Territories, Bangkok Noi, Changwat Songkhla, and Chiang Mai. The page reorganized location sections under a single Locations heading, removing some previously listed location subsections.SummaryDifference0.8%

Stay in the know with updates to FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page.